Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-13

Clinical Trial Update: Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study) [Phase 3]

View source ↗

Summary

Phase 3 trial updating on comparing TWA and EPS tests for predicting risk of life-threatening heart rhythms in ischemic cardiomyopathy with left ventricular dys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPS Test
  • TWA Test

Snippet

Sponsor: Abbott Medical Devices | Conditions: Ischemic Cardiomyopathy, LV Dysfunction | Phase 3 | Status: COMPLETED